Teva Sued Over Generic HIV Drug
ViiV is asking the court to issue an order blocking Israel-based Teva from making a generic version of Epzicom, also known as Kivexa. Teva's proposed generic will infringe a U.S. patent ViiV obtained in 2002, the suit claims.
“ViiV will be irreparably harmed by Teva's infringing...
To view the full article, register now.